Surgical Roundtable Case 3: Fixing a Tilted Secondary IOL - Scorecard - MDSpire

Surgical Roundtable Case 3: Fixing a Tilted Secondary IOL

Christina Weng, MD, MBA, presents a case of secondary IOL tilt correction, highlighting a novel 5-point scaffold technique for lens stabilization, and a panel of expert vitreoretinal surgeons discusses rescue strategies, IOL exchange vs preservation, and pearls for managing postoperative lens tilt.

  • By

  • Christina Y. Weng, MD, MBA

  • Mrinali Gupta, MD, FASRS

  • Nimesh A. Patel, MD

  • Frank Brodie, MD, MBA

  • July 1, 2026

  • 16 min

Share

Clinical Scorecard: Surgical Roundtable Case 3: Fixing a Tilted Secondary IOL

At a Glance

CategoryDetail
ConditionTilted Secondary Intraocular Lens (IOL)
Key Mechanisms5-point scaffold technique for lens stabilization
Target PopulationPatients with dislocated or tilted IOLs
Care SettingOphthalmic surgical practice

Key Highlights

  • Modified Yamane technique is favored for secondary IOL fixation.
  • Tilt of IOLs, such as the CT Lucia 602, can occur post-surgery.
  • Technique developed originally for silicone oil retention in aphakic eyes.

Guideline-Based Recommendations

Diagnosis

  • Assess IOL position and stability through clinical examination.

Management

  • Utilize the 5-point scaffold technique for correcting tilted IOLs.

Monitoring & Follow-up

  • Regular follow-up to evaluate IOL position and visual acuity.

Risks

  • Potential for IOL tilt recurrence and complications from surgical intervention.

Patient & Prescribing Data

Patients with previous IOL surgeries experiencing tilt.

The 5-point scaffold technique offers a less traumatic alternative to explantation.

Clinical Best Practices

  • Consider the modified Yamane technique for secondary IOL fixation.
  • Evaluate the need for explantation versus correction based on individual cases.

Related Resources & Content

    Original Source(s)

    Surgical Roundtable Case 3: Fixing a Tilted Secondary IOL

    • by Christina Y. Weng, MD, MBA, Mrinali Gupta, MD, FASRS, Nimesh A. Patel, MD, Frank Brodie, MD, MBA

    • July 1, 2026

    Related Content

    New Immune Target in Dry Eye

    Investigators say rexinoid therapy may represent a new class of dry eye treatment focused on regenerative immune signaling

    • June 30, 2026

    • 3 min
    Haag-Streit Announces Appointment of New CCO

    Anette Chauhan will lead the company’s global commercial activities and organization

    • June 29, 2026

    • 1 min
    Emerging Trends in Intraocular Tamponade